Insider Transactions in Q3 2024 at Iovance Biotherapeutics, Inc. (IOVA)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 03
2024
|
Finckenstein Friedrich Graf Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,874
-10.34%
|
$138,740
$10.85 P/Share
|
|
Sep 03
2024
|
Finckenstein Friedrich Graf Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
27,345
+16.02%
|
-
|
|
Sep 03
2024
|
Frederick G Vogt Interim CEO & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
24,339
-6.0%
|
$243,390
$10.85 P/Share
|
|
Sep 03
2024
|
Frederick G Vogt Interim CEO & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
57,292
+11.94%
|
-
|
|
Sep 03
2024
|
Jean Marc Bellemin Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,891
-28.83%
|
$118,910
$10.85 P/Share
|
|
Sep 03
2024
|
Jean Marc Bellemin Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,438
+36.24%
|
-
|
|
Sep 03
2024
|
Igor Bilinsky Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,675
-10.96%
|
$136,750
$10.85 P/Share
|
|
Sep 03
2024
|
Igor Bilinsky Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,954
+16.71%
|
-
|
|
Jul 15
2024
|
Igor Bilinsky Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,428
-3.35%
|
$11,424
$8.68 P/Share
|
|
Jul 15
2024
|
Igor Bilinsky Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,813
+6.2%
|
-
|
|
Jul 15
2024
|
Finckenstein Friedrich Graf Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,428
-3.02%
|
$11,424
$8.68 P/Share
|
|
Jul 15
2024
|
Finckenstein Friedrich Graf Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,813
+5.61%
|
-
|
|
Jul 15
2024
|
Frederick G Vogt Interim CEO & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
8,851
-5.26%
|
$70,808
$8.68 P/Share
|
|
Jul 15
2024
|
Frederick G Vogt Interim CEO & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
20,835
+11.02%
|
-
|